Clinical Trials Browser

Phase 1 × Withdrawn × SS1(dsFv)PE38 × Clear all

NCT00024674 2014-11-14

Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days

Phase 1 Withdrawn

Neoplasms

NCT00024687 2014-11-14

Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses

Phase 1 Withdrawn

Neoplasms